Silvercrest Asset Management Group LLC Has $14.22 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

Silvercrest Asset Management Group LLC decreased its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 2.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 105,858 shares of the medical research company's stock after selling 3,092 shares during the period. Silvercrest Asset Management Group LLC's holdings in Agilent Technologies were worth $14,221,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in A. Sienna Gestion boosted its position in shares of Agilent Technologies by 29.8% during the 4th quarter. Sienna Gestion now owns 78,445 shares of the medical research company's stock valued at $10,537,000 after acquiring an additional 17,991 shares in the last quarter. Sequoia Financial Advisors LLC lifted its stake in Agilent Technologies by 8.5% during the fourth quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company's stock worth $4,554,000 after purchasing an additional 2,664 shares during the period. Prudential PLC boosted its holdings in Agilent Technologies by 16.0% during the fourth quarter. Prudential PLC now owns 73,273 shares of the medical research company's stock valued at $9,843,000 after purchasing an additional 10,128 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in Agilent Technologies by 9.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 43,862 shares of the medical research company's stock valued at $5,892,000 after purchasing an additional 3,915 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in shares of Agilent Technologies by 16.0% in the 4th quarter. Daiwa Securities Group Inc. now owns 49,288 shares of the medical research company's stock valued at $6,621,000 after purchasing an additional 6,802 shares during the period.

Agilent Technologies Price Performance

NYSE:A traded down $1.87 during mid-day trading on Friday, reaching $107.81. 414,858 shares of the company were exchanged, compared to its average volume of 2,036,786. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The stock has a market cap of $30.74 billion, a PE ratio of 24.78, a PEG ratio of 3.07 and a beta of 1.27. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The company has a fifty day moving average of $109.72 and a 200 day moving average of $127.55.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, research analysts anticipate that Agilent Technologies, Inc. will post 5.54 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be given a $0.248 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.92%. Agilent Technologies's payout ratio is 22.76%.

Insider Activity

In other news, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. This trade represents a 4.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now owns 21,786 shares of the company's stock, valued at approximately $2,657,456.28. This represents a 8.05% decrease in their position. The disclosure for this sale can be found here.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Jefferies Financial Group cut their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Barclays cut their price objective on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. TD Cowen boosted their target price on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Thursday, April 10th. Robert W. Baird dropped their target price on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday. Finally, Wells Fargo & Company cut their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $141.42.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.